Global Neuropathic Pain Market and Forecast Analysis to 2024 - ResearchAndMarkets.com
May. 14, 2018
DUBLIN--(BUSINESS WIRE)--May 14, 2018--The "Neuropathic Pain Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering.
Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory system, resulting in symptoms that include burning, stabbing, shooting, or electric shock-like sensations, which substantially differentiate it from nociceptive pain. Neuropathic pain is not a single disease, but a syndrome caused by an array of different diseases and lesions, with common subtypes such as diabetic peripheral neuropathy, post-herpetic neuralgia, and chemotherapy-induced neuropathic pain.
Market SnapshotTreatment of neuropathic pain has remained stagnant over recent years due to lack of innovation within the pain market. The burden of neuropathic pain is difficult to estimate, but is likely high across all analyzed countries.
Key Topics Covered:
Treatment: Neuropathic PainOverview Executive Summary Primary Research Methodology Disease Definition And Diagnosis Patient Segmentation Current Treatment Options Prescribing Trends Unmet Needs In Neuropathic Pain
Epidemiology: Neuropathic PainOverview Disease Background Methodology Forecast Bibliography
For more information about this report visit https://www.researchandmarkets.com/research/w4khqk/global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180514005873/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Central Nervous System Drugs ,Analgesics
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 05/14/2018 10:43 AM/DISC: 05/14/2018 10:43 AM